Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Envafolimab with Trastuzumab and Docetaxel in HER2-positive Breast Cancer
NCT04034823Phase 2Unknown
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Sep 2019
- Primary completion
- Jan 2021
01
Overview
A Phase 2 trial of envafolimab in HER2-positive breast cancer, sponsored by Sun Yat-sen Memorial Hospital. Status: unknown.
02
Drugs
envafolimab
03
Conditions
HER2-positive breast cancer
Beyond the preview
Go deeper on NCT04034823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04034823.